Literature DB >> 6207171

Amino acid sequences of helospectins, new members of the glucagon superfamily, found in Gila monster venom.

D S Parker, J P Raufman, T L O'Donohue, M Bledsoe, H Yoshida, J J Pisano.   

Abstract

The amino acid sequences of two closely related peptides from Gila monster (Heloderma suspectum) venom are reported. Helospectin I is a 38-residue peptide, His-Ser-Asp-Ala-Thr-Phe-Thr-Ala-Glu-Tyr-Ser-Lys-Leu-Leu-Ala-Lys-Leu-Ala- Leu-Gln - Lys-Tyr-Leu-Glu-Ser-Ile-Leu-Gly-Ser-Ser-Thr-Ser-Pro-Arg-Pro-Pro-Ser-Ser, and helospectin II is a 37-residue peptide identical to helospectin I except that it lacks serine 38. Helospectins are pancreatic secretagogues with structures and bioactivities similar to vasoactive intestinal peptide and other members of the glucagon superfamily. The relative significance of helospectin-I and helospectin-II is presently unknown. Comparison of the 28 residues of vasoactive intestinal peptide with residues 1-28 of helospectin shows that identical amino acids occur in 15 positions. Since members of the glucagon superfamily have similar structures but different biological actions, it is possible that helospectin is more closely related to a mammalian peptide awaiting discovery.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6207171

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Helodermin and islet hormone release in isolated rat pancreas.

Authors:  H C Fehmann; R Göke; B Göke; R Eissele; R Arnold
Journal:  Int J Pancreatol       Date:  1991-05

2.  Vascular effects of helodermin, helospectin I and helospectin II: a comparison with vasoactive intestinal peptide (VIP).

Authors:  L Grundemar; E D Högestätt
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

3.  Black widow spider alpha-latrotoxin: a presynaptic neurotoxin that shares structural homology with the glucagon-like peptide-1 family of insulin secretagogic hormones.

Authors:  G G Holz; J F Habener
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  1998-10       Impact factor: 2.231

4.  Effects of helospectin I on insulin and glucagon secretion in the mouse.

Authors:  B Ahrén
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

5.  Pituitary adenylate cyclase-activating polypeptide (PACAP): occurrence in rodent pancreas and effects on insulin and glucagon secretion in the mouse.

Authors:  T Fridolf; F Sundler; B Ahrén
Journal:  Cell Tissue Res       Date:  1992-08       Impact factor: 5.249

6.  Distribution and effects of pituitary adenylate cyclase activating peptide in cat and human lower oesophageal sphincter.

Authors:  L Ny; B Larsson; P Alm; P Ekström; J Fahrenkrug; J Hannibal; K E Andersson
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

7.  Pituitary adenylate cyclase-activating peptide (PACAP), a new vasoactive intestinal peptide (VIP)-like peptide in the respiratory tract.

Authors:  R Uddman; A Luts; A Arimura; F Sundler
Journal:  Cell Tissue Res       Date:  1991-07       Impact factor: 5.249

8.  Helodermin, helospectin, and PACAP stimulate cyclic AMP formation in intact bone, isolated osteoblasts, and osteoblastic cell lines.

Authors:  U H Lerner; P Lundberg; M Ransjö; P Persson; R Håkanson
Journal:  Calcif Tissue Int       Date:  1994-04       Impact factor: 4.333

9.  Pituitary adenylate cyclase-activating polypeptide, helospectin, and vasoactive intestinal polypeptide in human corpus cavernosum.

Authors:  P Hedlund; P Alm; P Ekström; J Fahrenkrug; J Hannibal; H Hedlund; B Larsson; K E Andersson
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

10.  Nitric oxide synthase-containing, peptide-containing, and acetylcholinesterase-positive nerves in the cat lower oesophagus.

Authors:  L Ny; P Alm; P Ekström; J Hannibal; B Larsson; K E Andersson
Journal:  Histochem J       Date:  1994-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.